Tirzepatide is a dual GIP and GLP-1 receptor agonist designed to improve blood sugar control and support significant weight loss. By mimicking natural gut hormones, it enhances insulin sensitivity, suppresses appetite, and promotes fat metabolism, making it a groundbreaking treatment for type 2 diabetes and obesity.
Disclaimer: This peptide is for research and educational purposes only. It is not intended for diagnostic or therapeutic use without the guidance of a qualified healthcare professional.
